Status:
UNKNOWN
Evaluation of Performance and Usability of N6 in the Paediatric Population
Lead Sponsor:
Cochlear, Asia Pacific
Collaborating Sponsors:
The HEARing Co-operative Research Centre, Melbourne
Melbourne Cochlear Implant Clinic, Melbourne
Conditions:
Transplants and Implants
Hearing Loss
Eligibility:
All Genders
5-14 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the performance and usability of the N6 system in children with the N5 system.
Detailed Description
This study will evaluate the user benefits of the N6 system in the paediatric population currently equipped with N5. The performance and usability of both systems will be evaluated and compared. The p...
Eligibility Criteria
Inclusion
- Age 5-14 years, currently using N5
- Minimum speech perception ability in noise of 30% at +10 decibels (dB) signal-to-noise ratio (SNR).
- Minimum of 2 years cochlear implant (CI) experience, including at least 6 months experience with their current processor
- Excellent verbal reporters
- Excellent record of attending clinical appointments.
- Attend a regular school,
- English 1st language.
- Excellent record of compliance with habilitation tasks.
Exclusion
- Cognitive impairment, or other significant impairment that would impact on their ability to undertake task requirements
- Inability to attend study appointments.
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01800929
Start Date
November 1 2012
End Date
June 1 2013
Last Update
March 1 2013
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
The Shepherd Centre
Sydney, New South Wales, Australia, 2008
2
Hear and Say Centre
Brisbane, Queensland, Australia, 4066
3
Melbourne Cochlear Implant Clinic
Melbourne, Victoria, Australia, 3002
4
The Hearing House
Auckland, New Zealand